K562/AZQR

Cat.No.: CSC-C9504J

Species: Homo sapiens (Human)

Source: Pleural Effusion

Morphology: Lymphoblastoid

Culture Properties: Suspension

  • Specification
  • Q & A
  • Customer Review
Cat.No.
CSC-C9504J
Description
The drug resistant cell line K562 AZQ has been developed from the parent K562 cell line by treatment with AZQ C215-bis (carboethoxyamino)-3, 6-diazitinyl 1;4 (benzoquinone). The cells have been shown to contain decreased levels of glutathione and superoxoid dismutase. They are cross-resistant to adriamycin, mitzolamide, MMNG and mitmycin. Cells should be challenged with AZQ at every 4th passage at a minimum density of 100,000 cells/ml. It is recommended to cultivate the cells without drug on resuscitation.
Species
Homo sapiens (Human)
Source
Pleural Effusion
Recommended Medium
RPMI 1640 + 10% Fetal Bovine Serum (FBS) + 2mM Glutamine. Challenge with 1 mM AZQ every 4th passage.
Culture Properties
Suspension
Morphology
Lymphoblastoid
Disease
Chronic Myeloid Leukemia
Storage and Shipping
Creative Bioarray ships frozen cells on dry ice. On receipt, immediately transfer frozen cells to liquid nitrogen (-180 °C) until ready for experimental use.
Never can cryopreserved cells be kept at -20 °C.
Synonyms
K562 AZQR; K562-AZQR; K562AZQR; AZQR
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products